UNSPSC 51284025: Doxycycline calcium

This classification denotes a tetracycline antibiotic C22H24N2O8.2Ca, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 8ZL07I20SB, chemically known as 2-naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, (4s-(4a,4aa,5a,5aa,6a,12aa))-, calcium salt (2:1), but more generally known as doxycycline calcium, which bears US NIH Compound Identifier 62305.

UNSPSC 51284025 Doxycycline calcium is a Commodity code whose recent activity shows limited direct solicitation for the named product itself; instead, state and local buyers are procuring pharmaceuticals and medical supplies through broader categories that encompass generic multi-source drugs, OTC products, and emergency medical consumables. The code's scope reflects what health departments, fire rescue divisions, and pharmacy benefit programs actually need — finished pharmaceutical products for distribution through established wholesale channels or direct dispensing to public-safety and healthcare facilities. Issuing bodies include state health agencies (Texas Health and Human Services Commission), county health departments (Seminole County, Florida), municipal fire departments (City of Tampa), and regional cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance serving multiple states including Oregon). Recent solicitations show issuing bodies managing procurement either through direct awards to manufacturers or through authorized wholesalers (AmerisourceBergen, Cardinal Health, Morris & Dickson) that serve as intermediaries.

Geographic activity centers on the upper Midwest (Minnesota cooperative purchasing), Texas (state HHS Commission), and Florida (Seminole County), with representation from the Southwest (City of Tampa). Representative recent opportunities include the Minnesota Multistate Cooperative Purchasing Alliance's RFP for generic multi-source pharmaceuticals and OTC products with proposals due March 26, 2026, specifying three authorized wholesalers and requiring NDC compliance and cGMP certification; Seminole County's IFB 60459723LAS for naloxone and drug deactivation systems (1,900 units naloxone, 800 deactivation units annually) with quarterly deliveries due July 26, 2026; the City of Tampa's ITB 26-P-00145 for medical and first aid supplies ($700,000 estimated value) designated as a Small Local Business Enterprise set-aside with a 5% bid discount, due March 13, 2026; and the Texas HHS Commission's RFI HHS0017013 soliciting vendor capabilities for direct-to-manufacturer prescription programs with responses due April 3, 2026.